[
  {
    "ts": null,
    "headline": "Waters Merger With BD Unit Shifts Focus Toward Diagnostics And Valuation",
    "summary": "Waters Corporation (NYSE:WAT) plans to merge with BD's life science and diagnostics business, targeting completion in early 2026. The transaction is expected to shift Waters' business mix toward diagnostics and life science tools. Shareholders are watching for how this combination could influence future revenue sources and competitive position. Waters, trading at around $326.3 per share, is approaching this planned merger after a period of mixed share performance. The stock is up 1.5% over...",
    "url": "https://finnhub.io/api/news?id=d65e73a986e94302a35667b8c0ad337e920936dec4ca4be89595317f095ea2c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771999844,
      "headline": "Waters Merger With BD Unit Shifts Focus Toward Diagnostics And Valuation",
      "id": 139205269,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Waters Corporation (NYSE:WAT) plans to merge with BD's life science and diagnostics business, targeting completion in early 2026. The transaction is expected to shift Waters' business mix toward diagnostics and life science tools. Shareholders are watching for how this combination could influence future revenue sources and competitive position. Waters, trading at around $326.3 per share, is approaching this planned merger after a period of mixed share performance. The stock is up 1.5% over...",
      "url": "https://finnhub.io/api/news?id=d65e73a986e94302a35667b8c0ad337e920936dec4ca4be89595317f095ea2c2"
    }
  }
]